JP2024534034A5 - - Google Patents
Info
- Publication number
- JP2024534034A5 JP2024534034A5 JP2024508965A JP2024508965A JP2024534034A5 JP 2024534034 A5 JP2024534034 A5 JP 2024534034A5 JP 2024508965 A JP2024508965 A JP 2024508965A JP 2024508965 A JP2024508965 A JP 2024508965A JP 2024534034 A5 JP2024534034 A5 JP 2024534034A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163233343P | 2021-08-16 | 2021-08-16 | |
| US63/233,343 | 2021-08-16 | ||
| US202263322273P | 2022-03-22 | 2022-03-22 | |
| US63/322,273 | 2022-03-22 | ||
| PCT/US2022/074891 WO2023023465A1 (en) | 2021-08-16 | 2022-08-12 | Anti-vegfr1 antibodies and their uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534034A JP2024534034A (ja) | 2024-09-18 |
| JP2024534034A5 true JP2024534034A5 (enExample) | 2025-08-19 |
Family
ID=85239767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508965A Pending JP2024534034A (ja) | 2021-08-16 | 2022-08-12 | 抗ｖｅｇｆｒ１抗体及びそれらの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240425603A1 (enExample) |
| EP (1) | EP4388011A4 (enExample) |
| JP (1) | JP2024534034A (enExample) |
| KR (1) | KR20240046239A (enExample) |
| CN (1) | CN119285771A (enExample) |
| AU (1) | AU2022331414A1 (enExample) |
| CA (1) | CA3229430A1 (enExample) |
| CL (1) | CL2024000445A1 (enExample) |
| CO (1) | CO2024001686A2 (enExample) |
| IL (1) | IL310840A (enExample) |
| MX (1) | MX2024002112A (enExample) |
| TW (1) | TW202315888A (enExample) |
| UY (1) | UY39900A (enExample) |
| WO (1) | WO2023023465A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024226943A1 (en) * | 2023-04-26 | 2024-10-31 | Seismic Therapeutic, Inc. | Molecules for modulating the immune system and uses thereof |
| WO2026072909A2 (en) * | 2024-09-27 | 2026-04-02 | Amgen Inc. | Flt1 binding proteins and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3519B1 (ar) * | 2013-01-25 | 2020-07-05 | Amgen Inc | تركيبات أجسام مضادة لأجل cdh19 و cd3 |
| TW201517916A (zh) * | 2013-03-15 | 2015-05-16 | Lilly Co Eli | Ｖｅｇｆｒ１抗體之治療用途 |
| MX391847B (es) * | 2015-04-07 | 2025-03-21 | Takeda Pharmaceuticals Co | Anticuerpos anti-flt-1 para tratar displasia broncopulmonar. |
| AU2020299600A1 (en) * | 2019-07-03 | 2022-01-06 | Crystal Bioscience Inc. | Anti-CD38 antibody and methods of use thereof |
| CN110452297B (zh) * | 2019-09-03 | 2020-04-14 | 上海洛启生物医药技术有限公司 | 抗vegf单域抗体及其应用 |
-
2022
- 2022-08-12 KR KR1020247008451A patent/KR20240046239A/ko active Pending
- 2022-08-12 CA CA3229430A patent/CA3229430A1/en active Pending
- 2022-08-12 WO PCT/US2022/074891 patent/WO2023023465A1/en not_active Ceased
- 2022-08-12 IL IL310840A patent/IL310840A/en unknown
- 2022-08-12 CN CN202411407118.6A patent/CN119285771A/zh active Pending
- 2022-08-12 MX MX2024002112A patent/MX2024002112A/es unknown
- 2022-08-12 AU AU2022331414A patent/AU2022331414A1/en active Pending
- 2022-08-12 JP JP2024508965A patent/JP2024534034A/ja active Pending
- 2022-08-12 EP EP22859291.1A patent/EP4388011A4/en active Pending
- 2022-08-12 US US18/683,892 patent/US20240425603A1/en active Pending
- 2022-08-15 TW TW111130548A patent/TW202315888A/zh unknown
- 2022-08-15 UY UY0001039900A patent/UY39900A/es unknown
-
2024
- 2024-02-14 CL CL2024000445A patent/CL2024000445A1/es unknown
- 2024-02-16 CO CONC2024/0001686A patent/CO2024001686A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12331119B2 (en) | Modified Fc fragment, antibody comprising same, and application thereof | |
| JP2023528350A5 (enExample) | ||
| JP2024535712A5 (enExample) | ||
| JP2018517401A5 (enExample) | ||
| US20220119549A1 (en) | Shielded biologics with masking domains to shield antigen binding capability of biologics and uses thereof | |
| RU2019108429A (ru) | Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения | |
| TW201932494A (zh) | 自單特異性抗體於活體內產生多特異性抗體之方法 | |
| US20230174648A1 (en) | Sirp alpha and sirp beta 1 antibodies and uses thereof | |
| JP2021534797A5 (enExample) | ||
| JP2023522730A5 (enExample) | ||
| JP2024534034A5 (enExample) | ||
| WO2019195313A1 (en) | Anti-vegf antagonist and pedf agonist constructs and uses thereof | |
| JP2021525059A5 (enExample) | ||
| US20250230248A1 (en) | Anti-egfr antibodies, anti-cmet antibodies, anti-vegf antibodies, multispecific antibodies, and uses thereof | |
| US12421320B2 (en) | Protein S antibodies, methods of making and uses thereof | |
| JP2024532372A5 (enExample) | ||
| JP2024502863A5 (enExample) | ||
| JP2022540846A (ja) | Ｔｎｆ－アルファおよびｉｌ－１ベータに対する二特異性抗体ならびにその使用 | |
| WO2021150266A1 (en) | Agents that interfere with il-1beta receptor signalling | |
| RU2024107310A (ru) | Радиоконъюгаты к psma и способы их применения | |
| US20250154287A1 (en) | ANTI-MIGIS-alpha ANTIBODIES AND METHODS OF USE THEREOF | |
| US20260070969A1 (en) | Il-17 binding proteins, compositions, and methods of use thereof | |
| US20260055171A1 (en) | Vegf antagonists and methods of use thereof | |
| RU2022110238A (ru) | Индуцирующий цитотоксичность терапевтический агент | |
| NZ769634B2 (en) | Anti-sirpa antibodies and methods of use thereof |